TP53 in Myelodysplastic Syndromes

SIMPLE SUMMARY: The importance of gene variants in the prognosis of myelodysplastic syndromes (MDSs) has been repeatedly reported in recent years. Especially, TP53 mutations are independently associated with a higher risk category, resistance to conventional therapies, rapid transformation to leukem...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yan, Gao, Su-Jun, Soubise, Benoit, Douet-Guilbert, Nathalie, Liu, Zi-Ling, Troadec, Marie-Bérengère
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582368/
https://www.ncbi.nlm.nih.gov/pubmed/34771553
http://dx.doi.org/10.3390/cancers13215392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582368/
https://www.ncbi.nlm.nih.gov/pubmed/34771553
http://dx.doi.org/10.3390/cancers13215392

Ejemplares similares